24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release.

Saved in:
Bibliographic Details
Title: 24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release.
Authors: Azar P; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Li VW; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Wong JSH; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Addictions and Concurrent Disorders Research Group, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Nikoo M; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Machado J; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada., Ignaszewski MJ; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.; Substance Use Response and Facilitation Service, BC Children's Hospital, Provincial Health Services Authority, BC, Canada., Mathew N; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.; BC Mental Health & Substance Use Services, Provincial Health Services Authority, BC, Canada., Raheemullah A; Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, USA., Wakeman SE; Department of Medicine, Massachusetts General Hospital, Boston, USA.; Department of Medicine, Harvard Medical School, Boston, USA., Mullen R; The C4 Foundation, Coronado, CA, USA., Krausz RM; Addictions and Concurrent Disorders Research Group, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Montaner JSG; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada., Maharaj AR; Pharmacokinetics Modeling and Simulation Laboratory, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
Source: Journal of psychoactive drugs [J Psychoactive Drugs] 2026 Apr-Jun; Vol. 58 (2), pp. 166-170. Date of Electronic Publication: 2024 Nov 19.
Publication Type: Journal Article; Case Reports
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 8113536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-9777 (Electronic) Linking ISSN: 02791072 NLM ISO Abbreviation: J Psychoactive Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39560320
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Azar+P%22">Azar P</searchLink>; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Li+VW%22">Li VW</searchLink>; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Wong+JSH%22">Wong JSH</searchLink>; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Addictions and Concurrent Disorders Research Group, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Nikoo+M%22">Nikoo M</searchLink>; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Machado+J%22">Machado J</searchLink>; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Ignaszewski+MJ%22">Ignaszewski MJ</searchLink>; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.; Substance Use Response and Facilitation Service, BC Children's Hospital, Provincial Health Services Authority, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Mathew+N%22">Mathew N</searchLink>; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.; BC Mental Health & Substance Use Services, Provincial Health Services Authority, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Raheemullah+A%22">Raheemullah A</searchLink>; Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, USA.<br /><searchLink fieldCode="AU" term="%22Wakeman+SE%22">Wakeman SE</searchLink>; Department of Medicine, Massachusetts General Hospital, Boston, USA.; Department of Medicine, Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Mullen+R%22">Mullen R</searchLink>; The C4 Foundation, Coronado, CA, USA.<br /><searchLink fieldCode="AU" term="%22Krausz+RM%22">Krausz RM</searchLink>; Addictions and Concurrent Disorders Research Group, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Montaner+JSG%22">Montaner JSG</searchLink>; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Maharaj+AR%22">Maharaj AR</searchLink>; Pharmacokinetics Modeling and Simulation Laboratory, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228113536%22">Journal of psychoactive drugs</searchLink> [J Psychoactive Drugs] 2026 Apr-Jun; Vol. 58 (2), pp. 166-170. <i>Date of Electronic Publication: </i>2024 Nov 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Case Reports
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8113536 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2159-9777 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202791072%22">02791072 </searchLink><i>NLM ISO Abbreviation: </i>J Psychoactive Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39560320
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/02791072.2024.2430616
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 166
    Titles:
      – TitleFull: 24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Azar P
      – PersonEntity:
          Name:
            NameFull: Li VW
      – PersonEntity:
          Name:
            NameFull: Wong JSH
      – PersonEntity:
          Name:
            NameFull: Nikoo M
      – PersonEntity:
          Name:
            NameFull: Machado J
      – PersonEntity:
          Name:
            NameFull: Ignaszewski MJ
      – PersonEntity:
          Name:
            NameFull: Mathew N
      – PersonEntity:
          Name:
            NameFull: Raheemullah A
      – PersonEntity:
          Name:
            NameFull: Wakeman SE
      – PersonEntity:
          Name:
            NameFull: Mullen R
      – PersonEntity:
          Name:
            NameFull: Krausz RM
      – PersonEntity:
          Name:
            NameFull: Montaner JSG
      – PersonEntity:
          Name:
            NameFull: Maharaj AR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr-Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2159-9777
          Numbering:
            – Type: volume
              Value: 58
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of psychoactive drugs
              Type: main
ResultId 1